Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 216, Issue 5, Pages 594-603
Publisher
Oxford University Press (OUP)
Online
2017-05-17
DOI
10.1093/infdis/jix244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of Genital Human Papillomavirus in Males, United States, 2013–2014
- (2017) Julia W. Gargano et al. JOURNAL OF INFECTIOUS DISEASES
- Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007–2014
- (2016) Elaine W. Flagg et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community
- (2016) Jessica A. Kahn et al. CLINICAL INFECTIOUS DISEASES
- Prevalence of HPV After Introduction of the Vaccination Program in the United States
- (2016) Lauri E. Markowitz et al. PEDIATRICS
- Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
- (2016) Elissa Meites et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2015
- (2016) Sarah Reagan-Steiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
- (2014) K Kavanagh et al. BRITISH JOURNAL OF CANCER
- Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
- (2014) Sepehr N Tabrizi et al. LANCET INFECTIOUS DISEASES
- Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2003–2010: Potential Impact of Human Papillomavirus Vaccination
- (2013) Elaine W. Flagg et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
- (2013) Lauri E. Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
- (2013) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Vaccine-Type Human Papillomavirus and Evidence of Herd Protection After Vaccine Introduction
- (2012) J. A. Kahn et al. PEDIATRICS
- "Herd Immunity": A Rough Guide
- (2011) P. Fine et al. CLINICAL INFECTIOUS DISEASES
- Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003–2006
- (2011) Susan Hariri et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Estimating Model-Adjusted Risks, Risk Differences, and Risk Ratios From Complex Survey Data
- (2010) G. S. Bieler et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started